Hanagasi_2017_J.Neurol.Sci_374_26

Reference

Title : Dementia in Parkinson's disease - Hanagasi_2017_J.Neurol.Sci_374_26
Author(s) : Hanagasi HA , Tufekcioglu Z , Emre M
Ref : Journal of Neurology Sci , 374 :26 , 2017
Abstract :

Dementia can occur in a substantial number of patients with Parkinson's disease with a point prevalence close to 30%. The cognitive profile is characterized by predominant deficits in executive, visuospatial functions, attention and memory. Behavioral symptoms are frequent such as apathy, visual hallucinations and delusions. The most prominent associated pathology is Lewy body-type and biochemical deficit is cholinergic. Placebo-controlled randomized trials with cholinesterase inhibitors demonstrated modest but significant benefits in cognition, behavioral symptoms and global functions.

PubMedSearch : Hanagasi_2017_J.Neurol.Sci_374_26
PubMedID: 28088312

Related information

Citations formats

Hanagasi HA, Tufekcioglu Z, Emre M (2017)
Dementia in Parkinson's disease
Journal of Neurology Sci 374 :26

Hanagasi HA, Tufekcioglu Z, Emre M (2017)
Journal of Neurology Sci 374 :26